Cargando…

Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?

Introduction The triple assessment for a lump in the breast is standard practice and the robustness of assessment towards the diagnosis of breast cancer is crucial. The combination of the modalities, physical examination, imaging (mammogram and ultrasound), and fine-needle aspiration cytology (FNAC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Karim, Muhammad Osman, Khan, Kashuf A, Khan, Abdul Jalil, Javed, Ayesha, Fazid, Sheraz, Aslam, Muhammad Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188022/
https://www.ncbi.nlm.nih.gov/pubmed/32351857
http://dx.doi.org/10.7759/cureus.7479
_version_ 1783527262588502016
author Karim, Muhammad Osman
Khan, Kashuf A
Khan, Abdul Jalil
Javed, Ayesha
Fazid, Sheraz
Aslam, Muhammad Imran
author_facet Karim, Muhammad Osman
Khan, Kashuf A
Khan, Abdul Jalil
Javed, Ayesha
Fazid, Sheraz
Aslam, Muhammad Imran
author_sort Karim, Muhammad Osman
collection PubMed
description Introduction The triple assessment for a lump in the breast is standard practice and the robustness of assessment towards the diagnosis of breast cancer is crucial. The combination of the modalities, physical examination, imaging (mammogram and ultrasound), and fine-needle aspiration cytology (FNAC) is more accurate than any modality alone. Aim To examine the combined and individual predictive values of physical examination (P), mammography (M), ultrasound (U), FNAC (C), with core biopsy (B) - triple assessment in the diagnosis of breast cancer. Methods To obtain the results of physical examination (P), mammography (M), ultrasound (U), FNAC (C), and core biopsy (B), we examined the records of 124 breast cancer patients seen between April 1, 2009, and March 30, 2010. To assess the diagnostic potential of the combination of the modalities (P, U, and M), we considered all cases with a score of 4 (probably malignant) and 5 (malignant) as positive for malignancy. All cases with a score of 3 (equivocal), 2 (benign), and 1 (normal) were considered negative for malignancy. For FNAC, a score of 1 (insufficient sample), 2 (benign), and 3 (atypia/probably benign) were considered. All the patients were diagnosed with breast cancer on excision biopsy. Among 124 patients, 12 were excluded, as they were unfit for intervention. Results The accuracy of physical examination (P) as confirmed by core biopsy (B) is dependent on the experience of the surgeon. It has limitations in younger women and smaller lesions. In our study, P has a positive predictive value (PPV) of 58.9% when compared with surgical biopsy, which is comparable with other studies. Our results showed PPV 66.1% and after an ultrasound scan, the overall radiological grading (M & U) gives a PPV of 81.3%, reflecting the important role of ultrasound scans. Our results showed the sensitivity of FNAC to be 73.2%. Core biopsy was diagnostic in 107 (95.5%) patients, making it a reliable tool. Our results confirmed that a combination of the modalities (P, M, U, R, FNAC) is more accurate than any modality alone. Conclusion When all the three modalities are positive for a diagnosis of malignant breast disease, surgical biopsy confirms the breast cancer diagnosis with a PPV of 100% and a sensitivity of 95.5%.
format Online
Article
Text
id pubmed-7188022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-71880222020-04-29 Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient? Karim, Muhammad Osman Khan, Kashuf A Khan, Abdul Jalil Javed, Ayesha Fazid, Sheraz Aslam, Muhammad Imran Cureus Pathology Introduction The triple assessment for a lump in the breast is standard practice and the robustness of assessment towards the diagnosis of breast cancer is crucial. The combination of the modalities, physical examination, imaging (mammogram and ultrasound), and fine-needle aspiration cytology (FNAC) is more accurate than any modality alone. Aim To examine the combined and individual predictive values of physical examination (P), mammography (M), ultrasound (U), FNAC (C), with core biopsy (B) - triple assessment in the diagnosis of breast cancer. Methods To obtain the results of physical examination (P), mammography (M), ultrasound (U), FNAC (C), and core biopsy (B), we examined the records of 124 breast cancer patients seen between April 1, 2009, and March 30, 2010. To assess the diagnostic potential of the combination of the modalities (P, U, and M), we considered all cases with a score of 4 (probably malignant) and 5 (malignant) as positive for malignancy. All cases with a score of 3 (equivocal), 2 (benign), and 1 (normal) were considered negative for malignancy. For FNAC, a score of 1 (insufficient sample), 2 (benign), and 3 (atypia/probably benign) were considered. All the patients were diagnosed with breast cancer on excision biopsy. Among 124 patients, 12 were excluded, as they were unfit for intervention. Results The accuracy of physical examination (P) as confirmed by core biopsy (B) is dependent on the experience of the surgeon. It has limitations in younger women and smaller lesions. In our study, P has a positive predictive value (PPV) of 58.9% when compared with surgical biopsy, which is comparable with other studies. Our results showed PPV 66.1% and after an ultrasound scan, the overall radiological grading (M & U) gives a PPV of 81.3%, reflecting the important role of ultrasound scans. Our results showed the sensitivity of FNAC to be 73.2%. Core biopsy was diagnostic in 107 (95.5%) patients, making it a reliable tool. Our results confirmed that a combination of the modalities (P, M, U, R, FNAC) is more accurate than any modality alone. Conclusion When all the three modalities are positive for a diagnosis of malignant breast disease, surgical biopsy confirms the breast cancer diagnosis with a PPV of 100% and a sensitivity of 95.5%. Cureus 2020-03-30 /pmc/articles/PMC7188022/ /pubmed/32351857 http://dx.doi.org/10.7759/cureus.7479 Text en Copyright © 2020, Karim et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Karim, Muhammad Osman
Khan, Kashuf A
Khan, Abdul Jalil
Javed, Ayesha
Fazid, Sheraz
Aslam, Muhammad Imran
Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title_full Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title_fullStr Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title_full_unstemmed Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title_short Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient?
title_sort triple assessment of breast lump: should we perform core biopsy for every patient?
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188022/
https://www.ncbi.nlm.nih.gov/pubmed/32351857
http://dx.doi.org/10.7759/cureus.7479
work_keys_str_mv AT karimmuhammadosman tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient
AT khankashufa tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient
AT khanabduljalil tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient
AT javedayesha tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient
AT fazidsheraz tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient
AT aslammuhammadimran tripleassessmentofbreastlumpshouldweperformcorebiopsyforeverypatient